- Industry veteran brings over 35 years of biotech experience as a successful entrepreneur and investor
- Operating experience to significantly enhance development program of CID-103 (anti-CD38 mAb)

Funding will fuel rapid expansion of the Columbus-based oncology platform, which connects community oncologists with subspecialty experts and real-world insights at the point of care.

With podcasting reaching over 210M people in the United States today, building reliable content for Providers and business professionals in healthcare is a crucial communication's tool.

Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment of general diarrhea globally

By combining experience in facial anatomy with advanced Sculptra injection strategies, Dr. Ran Rubinstein helps patients achieve gradual, long-lasting improvements in contour, skin quality, and facial harmony.

Mentavi's clinically validated, asynchronous ADHD assessment - recently published in the Journal of Clinical Psychiatry - shortens wait times from months to days and empowers students to access timely support.

The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population

The facility marks a cornerstone of Moderna's ten-year strategic partnership with the UK Government, designed to strengthen health resilience and drive economic growth

ComfoKnee Knee Brace Review 2025: Price, Complaints, Pros and Cons, Is It Legit or Not Worth It?

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price

San Diego-based Origin Modern Health & Wellness uses powerful, gentle root cause care, reconnecting individuals to their body's potential.

As rates of anxiety, burnout, and overwhelm reach record levels, the Encinitas-based center underscores self-care as a practical, community-driven approach to resilience.

The Encinitas facility shines a light on families, first responders, and individuals in recovery while calling for education, compassion, and action in the fight against addiction.

CLn Skin Care, a leader in dermatologist-developed therapeutic skincare, is proud to announce the launch of its new Hypochlorous Acid Spray, an FDA-cleared (510k Medical Device, HOCL 125 ppm, parts per million, concentration) daily cleansing solution designed to soothe, refresh, and support the natural healing of normal, irritated, sensitive, and damaged skin.

Dr. Javad Sajan at Allure Esthetic is the best facial feminization surgeon in the U.S.

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's Number One Killer

In partnership with RxERP Financial, the program offers up to $350,000 per pharmacy and $1 million per wholesaler or manufacturer through trusted third-party financing partners, strengthening cash flow and supply chain resilience.

Recognition in breast augmentation and liposuction highlights Dr. Doherty's expertise in two of the most requested cosmetic procedures, underscoring his reputation for natural outcomes and patient-centered care.

The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer

D-MNA and Teverelix collectively represent ~$8 billion in potential market opportunity

Comprehensive 2025 FootRenew Review With Real User Results, Common Complaints, Triple Method Technology Details, and Current Pricing

Full year fiscal 2025 net revenue of $66.4 million

Full year fiscal 2025 net loss of $13.6 million

Full year fiscal 2025 adjusted EBITDA¹ of $9.2 million

$31.0 million cash balance at June 30, 2025

Exclusive agreement in June 2025 to commercialize EXXUA™ (gepirone) extended-release tablets ("EXXUA") is expected to serve as a major growth catalyst; the Company anticipates launching EXXUA in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") market with what the Company believes to be a novel first-in-class oral selective serotonin 5HT1a receptor agonist for adults with MDD

Company to host conference call and webcast today, September 23, 2025, at 4:30 p.m. Eastern time

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Macular Degeneration

Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups

Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains

- Spora takes role in international consortium aiming to turn CO₂ into protein enough to feed more than 1 billion people every year

Connectivity failures, OS updates, and frustrated patients shouldn't be your problem. Silent devices, outsourced call centers, and disengaged patients create hidden risks and liability. Addison Care delivers fully integrated Virtual Care - engaging patients, protecting providers, and maximizing Medicare value.

Study demonstrated Ketamir-2 was safe and well tolerated at all dose levels, with a favorable safety and tolerability profile, with no severe or clinically significant adverse effects observed. The drug showed rapid and predictable absorption, a favorable duration of action supporting once-daily dosing, and no CNS side effects typically seen with ketamine.

Full 2025 Hewelth Pulse Oximeter Review with Pros, Cons, Pricing, and Key Complaints for Smarter Buying Decisions

Comprehensive 2025 Guide to RxTra Clinical Trials: In-Depth Reviews, Top Complaints, Pricing Facts, Key Features, and Proof of Legitimacy

IBYC, based in Richmond, BC, is a next-generation digital health company developing AI-powered telemedicine and wearable solutions to improve access to care anytime, anywhere. The company focuses on mobile health monitoring, senior and multilingual populations, and caregiver support through secure, real-time biometric data analysis and AI insights. Founded by entrepreneurs with 20+ years of China-Canada experience, IBYC integrates technology, compliance, and cross-border resources to build scalable, culturally competent healthcare platforms.

Addressing care gaps as 700,000 BC residents lack family doctors and seniors are set to grow 68% over the next two decades

Kevin R. Hanz, MD: Dallas' Choice for Best in Cosmetic Surgery, Liposuction, and Breast Augmentation